Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Molecular genetic approach to human meningioma: loss of genes on chromosome 22B R Seizinger, S de la Monte, L Atkins, et al.Journal of Neurosurgery|November 1, 1990
Clonal origin of pituitary adenomasL B Jacoby, E T Hedley-Whyte, K Pulaski, et al.Brain Research|July 23, 1986
Opioid peptides in Huntington's disease: alterations in prodynorphin and proenkephalin systemB R Seizinger, D C Liebisch, S J Kish, et al.Nature|October 19, 1995
Induction of the growth inhibitor IGF-binding protein 3 by p53L Buckbinder, R Talbott, S Velasco-Miguel, et al.Cancer Research|August 1, 1992
Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomasA von Deimling, D N Louis, K von Ammon, et al.Brain Pathology (Zurich, Switzerland)|January 1, 1993
Subsets of glioblastoma multiforme defined by molecular genetic analysisA von Deimling, K von Ammon, D Schoenfeld, et al.Journal of the National Cancer Institute|June 1, 1994
P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumorsJ Schneider, M P Rubio, M J Barbazán, et al.American Journal of Human Genetics|February 1, 1990
Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22G A Rouleau, B R Seizinger, W Wertelecki, et al.Annals of the New York Academy of Sciences|January 1, 1991
Molecular genetics of neurofibromatosis 2 and related tumors (acoustic neuroma and meningioma)B Fontaine, G A Rouleau, B R Seizinger, et al.International Journal of Cancer|October 21, 1993
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanomaJ S Castresana, M P Rubio, J J Vázquez, et al.Pageof 8